Issued Patents 2017
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9834786 | Nuclease-mediated targeting with large targeting vectors | David Frendewey, Wojtek Auerbach, David M. Valenzuela, Ka-Man Venus Lai | 2017-12-05 |
| 9820476 | Genetically modified non-human animals and methods of use thereof | Richard Flavell, Markus Manz, Anthony Rongvaux, Till Strowig, Tim Willinger +2 more | 2017-11-21 |
| 9718881 | Anti-Activin A antibodies and uses thereof | Jesper Gromada, Esther Latres, Andrew J. Murphy, Lori C. Morton | 2017-08-01 |
| 9708386 | Modified chimeric polypeptides with improved pharmacokinetic properties | Nicholas J. Papadopoulos, Samuel Davis | 2017-07-18 |
| 9708635 | Methods of making a nucleic acid encoding a human variable region | Andrew J. Murphy, Margaret Karow, Lynn Macdonald, Sean Stevens, Aris N. Economides +1 more | 2017-07-18 |
| 9677129 | Method for detecting the replacement of an endogenous allele with a modified allele by homologous recombination in a mouse ES cell | Aris N. Economides, Andrew J. Murphy, David M. Valenzuela, David Frendewey | 2017-06-13 |
| 9669069 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2017-06-06 |
| 9655352 | Humanized M-CSF mice | Andrew J. Murphy, Sean Stevens, Chozhavendan Rathinam, Elizabeth Eynon, Markus Manz +1 more | 2017-05-23 |
| 9554563 | Genetically modified mice and engraftment | Sean Stevens, Andrew J. Murphy, Richard Flavell, Elizabeth Eynon, Jorge Galan +3 more | 2017-01-31 |
| 9546384 | Methods and compositions for the targeted modification of a mouse genome | David Frendewey, Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela | 2017-01-17 |
| 9540449 | Anti-PCSK9 antibodies with pH-dependent binding characteristics | Nicholas J. Papadopoulos, Andrew J. Murphy, Neil Stahl | 2017-01-10 |